Seven Eight Capital, LP Eli Lilly & CO Transaction History

Seven Eight Capital, LP

$1.05 Billion
Q3 2024

A detailed history of Seven Eight Capital, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Seven Eight Capital, LP holds 5,827 shares of LLY stock, worth $4.64 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

5,827

Previous 2,118 175.12%

Holding current value

$4.64 Million

Previous $1.92 Million 169.27%

% of portfolio

0.49%

Previous 0.21%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $2.86 Million - $3.56 Million	3,709 Added 175.12%	5,827 $5.16 Million
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $911,886 - $1.14 Million	1,258 Added 146.28%	2,118 $1.92 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $6.49 Million - $8.68 Million	-10,957 Reduced 92.72%	860 $669,000
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $6.21 Million - $7.32 Million	11,817 New	11,817 $6.89 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $714,813 - $814,604	-2,411 Reduced 34.18%	4,643 $1.5 Million
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $1.97 Million - $2.31 Million	7,054 New	7,054 $2.29 Million
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $894,872 - $1.11 Million	-3,813 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $857,353 - $1.06 Million	3,813 New	3,813 $1.05 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $396,442 - $487,878	-1,789 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $323,003 - $417,803	1,789 New	1,789 $411,000
Q3 2018 Oct 18, 2018	SELL	$85.86 - $107.31 $319,399 - $399,193	-3,720 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$75.7 - $86.88 $281,604 - $323,193	3,720 New	3,720 $317,000
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $1.43 Million - $1.69 Million	-19,291 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $1.58 Million - $1.7 Million	19,291 New	19,291 $1.63 Million
Q3 2017 Oct 16, 2017	SELL	$77.07 - $85.54 $68,669 - $76,216	-891 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	891	891 $73,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Account

Seven Eight Capital, LP Eli Lilly & CO Transaction History